Latest News

• share
• favorite_border

A new era in the management of glaucoma is ushered in by a landmark study published in the Journal of Glaucoma, Official Journal of the World Glaucoma Association. Patients with primary open angle glaucoma (POAG) showed significant improvements of both ocular and general health after participating in a program of mindful meditation focused on breathing compared to the control group that did not partake.

• share
• favorite_border

Magdeburg, Germany, September 4, 2018 - About one third of patients who have suffered a stroke end up with low vision, losing up to half of their visual field. This partial blindness was long considered irreversible, but recent studies have shown that vision training after optic nerve and brain damage can help restore or improve vision.

• share
• favorite_border

Persistent psychological stress, which is widely recognized as a consequence of vision loss, is also a major contributor to its development and progression, according to a study now published in the EPMA Journal

• share
• favorite_border

In a study published in Scientific Reports, researchers from Magdeburg University (Germany) and The Chinese University of Hong Kong report that for rats and mice, repetitive transorbital alternating current stimulation (rtACS) may help preserve visual neurons from cell death after injury.

• share
• favorite_border

A new book by the world’s leading expert on vision restoration, Professor Bernhard A. Sabel, PhD, delivers information about how to better understand the impact of vision loss and new treatment options that could potentially help the more than 150 million people worldwide who suffer from partial blindness.

• share
• favorite_border

Vision loss due to glaucoma or optic nerve damage is generally considered irreversible. Now a new prospective, randomized, multi-center clinical trial demonstrates significant vision improvement in partially blind patients after 10 days of noninvasive, transorbital alternating current stimulation (ACS). In addition to activation of their residual vision, patients also experienced improvement in vision-related quality of life such as acuity, reading, mobility or orientation. The results are reported in PLOS ONE.

• share
• favorite_border

Der Verlust der Sehkraft durch Glaukom oder Schädigung des Sehnervs gilt als irreversibel. Jetzt zeigt eine prospektive, randomisierte, multizentrische, klinische Studie signifikante Verbesserungen des Sehvermögens in teilweise erblindeten Patienten nach 10 Tagen Behandlung mit nicht-invasiver, transorbitaler Wechselstromstimulation (alternating current stimulation, ACS). Die Behandlung führte zu der Aktivierung von Restsehleistungen und sehbezogenen Verbesserungen der Lebensqualität wie Sehschärfe, Lesen, Mobilität und Orientierung. Diese aktuellen Ergebnisse wurden in PLOS ONE berichtet.